Evidence map›Paper›PMID 26788200›Full record

ArticleOncology letters2015

2',4'-dihydroxychalcone, a flavonoid isolated from

Yuqing Sheng, Mingchang Zou, Yan Wang, Qiheng Li

RetractedOpen access · diamondAbstract readRetracted Publication
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yuqing ShengDepartment of Pharmacy, The First People's Hospital of Zhenjiang, Zhenjiang, Jiangsu 212002, P.R. China.
Mingchang ZouDepartment of Pharmacy, The First People's Hospital of Zhenjiang, Zhenjiang, Jiangsu 212002, P.R. China.
Yan WangDepartment of Pharmacy, The First People's Hospital of Zhenjiang, Zhenjiang, Jiangsu 212002, P.R. China.
Qiheng LiDepartment of Pharmacy, The First People's Hospital of Zhenjiang, Zhenjiang, Jiangsu 212002, P.R. China.
Central People's Hospital of Zhanjiang · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products are a promising source for the development of novel cancer therapies, due to their potential effectiveness and low toxicity profiles. As a main component of

Indexed as

2′,4′-dihydroxychalconeapoptosiscell cyclecyclin-dependent kinase inhibitor 1Bphosphatase and tensin homologprostate cancer

Identifiers

PMID26788200
PMCPMC4665268
OpenAlexW2113317622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.